Before visiting, please review our current visitor policies and COVID-19 information.

Decorative dot pattern background image.
Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image.

COVID-19 Treatment with Monoclonal Antibodies

Treatment Options
To discuss treatment options for COVID-19, contact your primary care provider’s office.

The Food and Drug Administration (FDA) has granted Emergency Use Authorization for investigational monoclonal antibodies, which could help the immune system better fight COVID-19 and prevent severe illness in high-risk individuals.

Here’s what you need to know:

  • What is monoclonal antibody treatment?
    Monoclonal antibody treatment (also known as monoclonal infusion therapy) uses lab-produced antibodies, similar to those that your immune system would produce in the event of COVID-19 infection. By immediately targeting COVID-19’s signature spike protein, these antibodies can prevent the virus from attacking important cells in your body until your immune system mounts its own response.

    While this treatment is already showing promising results, it cannot take the place of COVID-19 vaccination – the best way to reduce the likelihood of severe illness and hospitalization.
  • Who is eligible for the treatment?
    You may be eligible for monoclonal antibody treatment if you test positive for COVID-19 and:
    • Are at high risk for developing severe COVID-19 disease
    • Have not yet been admitted to the hospital for your COVID-19 infection
    • Are 18 years of age or older, consult with a Pediatrician or Family Practice provider for those that are under 18
  • When should monoclonal antibodies be given?
    Monoclonal antibodies should be administered as soon as possible after testing positive for COVID-19 and within 7 days of the onset of symptoms
  • How do I get the treatment?
    It’s important to know that monoclonal antibody supply is extremely limited. Not every eligible individual will be able to receive the treatment at this time – it is not prescribed or administered in the Methodist Health System emergency departments 
  • How is the treatment given?
    The infusion is given intravenously (into a vein via an IV). 
  • Where do I go and how long does it take to get?
    It is administered at a Methodist Health System monoclonal infusion site and the appointment usually takes 2-3 hours to complete

If you are interested in receiving monoclonal antibody treatment or want to see if you qualify, please contact your primary care provider.

Fact Sheets for monoclonal treatments:
Bebtelovimab (English)
Bebtelovimab (Spanish)

More COVID-19 Resources

Get access to state, national and international resources to help you and your family understand COVID-19 and how to protect yourselves.

View Resources